Publications for Nader El-Mallawany nader_kim@nymc.edu

  • El-Mallawany, N. K., Kamiyango, W., Slone, J. S., Villiera, J., Kovarik, C. L., Cox, C. M., . . . Mehta, P. S. (2016). Clinical factors associated with long-term complete remission versus poor response to chemotherapy in HIV-infected children and adolescents with Kaposi sarcoma receiving bleomycin and vincristine: A retrospective observational study. PLoS One, 11(4) [Article e0153335]. doi:10.1371/journal.pone.0153335

  • Hochberg, J., El-Mallawany, N. K., & Abla, O. (2016). Adolescent and young adult non-Hodgkin lymphoma. British Journal of Haematology, 173(4), 637-650. doi:10.1111/bjh.14074

  • Nash, M., Harrison, L., Shi, Q., El-Mallawany, N., Abikoff, C., Hochberg, J.,. . . Cairo, M. S. (2016). A pilot trial of unmatched human placental derived stem cells (HPDSCs) in conjunction with unrelated cord blood transplantation (UCBT) in children and young adults with malignant and non-malignant disease (IND 14949). Biology of Blood and Marrow Transplantation, 22(3), S143-S144. doi:10.1016/j.bbmt.2015.11.484

  • Stanley, C. C., Westmoreland, K. D., Heimlich, B. J., El-Mallawany, N. K., Wasswa, P., Mtete, I., . . . Gopal, S. (2016). Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi. British Journal of Haematology, 173(5), 705-712. doi:10.1111/bjh.13986

  • El-Mallawany, N. K., & Cairo, M. S. (2015). Advances in the diagnosis and treatment of childhood and adolescent B-cell non-Hodgkin lymphoma. Clinical Advances in Hematology & Oncology : H&O, 13(2), 113-123. This material can be found here.

  • El-Mallawany, N. K., Day, N., Ayello, J., Van De Ven, C., Conlon, K., Fermin, D., . . . Cairo, M. S. (2015). Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. European Journal of Cancer, 51(1), 92-100. doi:10.1016/j.ejca.2014.10.017

  • El-Mallawany, N., Kamiyango, W., Villiera, J., Kovarik, C., Schutze, G., . . . Mehta, P. (2014). Kaposi sarcoma in HIV-infected children: A novel clinical staging classification determines risk stratification. Pediatric Blood and Cancer, 61(S2), S158.

  • Hochberg, J. C., El-Mallawany, N. K., & Cairo, M. S. (2014). Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults. Clinical Lymphoma, Myeloma & Leukemia, 14(Suppl.), S6-S13. doi:10.1016/j.clml.2014.04.015